These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1434037)

  • 1. [Immunological detection of fecal occult blood-follow up study on patients with positive testing].
    Monma T; Tukiyama S; Suehiro H; Maruoka E; Imataka K; Okano K
    Rinsho Byori; 1992 Sep; 40(9):993-6. PubMed ID: 1434037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening for colorectal cancer and polyps].
    Krieger Y; Fraser D; Odes HS; Krugliak P; Fraser GM
    Harefuah; 1992 Mar; 122(6):354-6, 408. PubMed ID: 1582622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinico-pathological features of colorectal adenomatous polyps with negative results on immunochemical fecal occult blood test.
    Abdul Fattah AS; Nakama H; Kamijo N
    Eur J Med Res; 1997 Aug; 2(8):361-4. PubMed ID: 9262491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the occult blood test in screening for colorectal neoplasms. A prospective study using flexible endoscopy.
    Reilly JM; Ballantyne GH; Fleming FX; Zucker KA; Modlin IM
    Am Surg; 1990 Mar; 56(3):119-23. PubMed ID: 2316930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year follow-up of asymptomatic patients with negative fecal occult blood test results in whom clinically significant colorectal pathology was detected.
    Cauffman JG; Forsyth RA; Lapsys FX; Clark V
    Am J Gastroenterol; 1997 Nov; 92(11):2036-9. PubMed ID: 9362187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
    Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia.
    Nakama H; Yamamoto M; Kamijo N; Li T; Wei N; Fattah AS; Zhang B
    Hepatogastroenterology; 1999; 46(25):228-31. PubMed ID: 10228797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance for colorectal neoplasia: is patient adherence following treatment a problem?
    Myers RE; Bralow SP; Goldstein R; Jacobs M; Wolf TA; Engstrom PF
    Cancer Detect Prev; 1993; 17(6):609-17. PubMed ID: 8275513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The detection of colorectal cancer at an asymptomatic stage by screening is useful.
    Komuta K; Furui J; Haraguchi M; Kanematsu T
    Hepatogastroenterology; 2000; 47(34):1011-4. PubMed ID: 11020866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of different stool tests for the detection of cancer of the colon].
    Vogel T; Driemel C; Hauser A; Hansmann A; Lange S; Jonas M; Möslein G
    Dtsch Med Wochenschr; 2005 Apr; 130(14):872-7. PubMed ID: 15800820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting colorectal cancer with a large scale fecal occult blood testing program.
    Gregorio DI; Lolachi P; Hansen H
    Public Health Rep; 1992; 107(3):331-5. PubMed ID: 1594743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population colorectal cancer screening with fecal occult blood test.
    Rennert G; Rennert HS; Miron E; Peterburg Y
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and therapy of the patient with fecal occult blood loss: a decision analysis.
    Lashner BA; Silverstein MD
    Am J Gastroenterol; 1990 Sep; 85(9):1088-95. PubMed ID: 2117850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening for colorectal tumors using fecal occult blood studies].
    Restellini A; Margalith D; Bauerfeind P; Guyot J; Ollyo JB; Gonvers JJ; Blum AL
    Ther Umsch; 1989 Jun; 46(6):389-97. PubMed ID: 2667190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.